Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease ; volume:10 ; number:1 ; day:26 ; month:2 ; year:2018 ; pages:1-14 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (26.2.2018), 1-14, 12.2018

Creator
Contributor
Traschütz, Andreas
Widmann, Catherine N.
Kummer, Markus P.
Tacik, Pawel
Santarelli, Francesco
Jessen, Frank
Heneka, Michael T.
SpringerLink (Online service)

DOI
10.1186/s13195-018-0353-3
URN
urn:nbn:de:101:1-2018091001180111495571
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Brosseron, Frederic
  • Traschütz, Andreas
  • Widmann, Catherine N.
  • Kummer, Markus P.
  • Tacik, Pawel
  • Santarelli, Francesco
  • Jessen, Frank
  • Heneka, Michael T.
  • SpringerLink (Online service)

Other Objects (12)

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimer disease pathology and the cerebrospinal fluid proteome

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

Related objects